Skip to main content
Top
Published in: Ophthalmology and Therapy 3/2022

Open Access 01-06-2022 | Review

Light Signaling and Myopia Development: A Review

Authors: Pengbo Zhang, Huang Zhu

Published in: Ophthalmology and Therapy | Issue 3/2022

Login to get access

Abstract

Introduction

The aim of this article was to comprehensively review the relationship between light exposure and myopia with a focus on the effects of the light wavelength, illuminance, and contrast on the occurrence and progression of myopia.

Methods

This review was performed by searching PubMed data sets including research articles and reviews utilizing the terms “light”, “myopia”, “refractive error”, and “illuminance”, and the review was concluded in November 2021. Myopia onset and progression were closely linked with emmetropization and hyperopia. To better elucidate the mechanism of myopia, some of the articles that focused on this topic were included. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Results

The pathogenesis and prevention of myopia are not completely clear. Studies have provided evidence supporting the idea that light could affect eye growth in three ways. Changing the corresponding conditions will cause changes in the growth rate and mode of the eyes, and preliminary results have shown that FR/NIR (far red/near-infrared) light is effective for myopia in juveniles.

Conclusion

This review discusses the results of studies on the effects of light exposure on myopia with the aims of providing clues and a theoretical basis for the use of light to control the development of myopia and offering new ideas for subsequent studies.
Literature
53.
go back to reference Wang J, Cui J, Zhu H. Suppression of type I collagen in human scleral fibroblasts treated with extremely low-frequency electromagnetic fields. Mol Vis. 2013;19:885–93.PubMedPubMedCentral Wang J, Cui J, Zhu H. Suppression of type I collagen in human scleral fibroblasts treated with extremely low-frequency electromagnetic fields. Mol Vis. 2013;19:885–93.PubMedPubMedCentral
70.
go back to reference Bradley DV, Fernandes A, Lynn M, Tigges M, Boothe RG. Emmetropization in the rhesus monkey (Macaca mulatta): birth to young adulthood. Invest Ophthalmol Vis Sci. 1999;40:214–29.PubMed Bradley DV, Fernandes A, Lynn M, Tigges M, Boothe RG. Emmetropization in the rhesus monkey (Macaca mulatta): birth to young adulthood. Invest Ophthalmol Vis Sci. 1999;40:214–29.PubMed
88.
go back to reference Ashby R. Animal studies and the mechanism of myopia—protection by light? Optometry Vis Sci. 2016;93:2.CrossRef Ashby R. Animal studies and the mechanism of myopia—protection by light? Optometry Vis Sci. 2016;93:2.CrossRef
89.
go back to reference Norton TT, Siegwart JT Jr. Animal models of emmetropization: matching axial length to the focal plane. J Am Optom Assoc. 1995;66:405–14.PubMed Norton TT, Siegwart JT Jr. Animal models of emmetropization: matching axial length to the focal plane. J Am Optom Assoc. 1995;66:405–14.PubMed
93.
go back to reference Cernota N, Rucker FJ, Wallman J. When severe astigmatic blur reduces visual cues, monochromatic light impairs the choroidal component of lens compensation. Investig Ophthalmol Vis Sci. 2012;53:3443–3443. Cernota N, Rucker FJ, Wallman J. When severe astigmatic blur reduces visual cues, monochromatic light impairs the choroidal component of lens compensation. Investig Ophthalmol Vis Sci. 2012;53:3443–3443.
104.
go back to reference Britton S, Fellows M, Rucker F. Temporal frequency sensitivity of the emmetropization mechanism in chicks to color and luminance flicker without blue light. Invest Ophthalmol Vis Sci. 2013;54:5178. Britton S, Fellows M, Rucker F. Temporal frequency sensitivity of the emmetropization mechanism in chicks to color and luminance flicker without blue light. Invest Ophthalmol Vis Sci. 2013;54:5178.
113.
go back to reference Luo X, Li B, Li T, et al. Myopia induced by flickering light in guinea pig eyes is associated with increased rather than decreased dopamine release. Mol Vis. 2017;23:666–79.PubMedPubMedCentral Luo X, Li B, Li T, et al. Myopia induced by flickering light in guinea pig eyes is associated with increased rather than decreased dopamine release. Mol Vis. 2017;23:666–79.PubMedPubMedCentral
125.
go back to reference Purushothuman S, Johnstone DM, Nandasena C, Mitrofanis J, Stone J. Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex—evidence from two transgenic mouse models. Alzheimers Res Therapy. 2014;6:2. https://doi.org/10.1186/alzrt232.CrossRef Purushothuman S, Johnstone DM, Nandasena C, Mitrofanis J, Stone J. Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex—evidence from two transgenic mouse models. Alzheimers Res Therapy. 2014;6:2. https://​doi.​org/​10.​1186/​alzrt232.CrossRef
126.
Metadata
Title
Light Signaling and Myopia Development: A Review
Authors
Pengbo Zhang
Huang Zhu
Publication date
01-06-2022
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy / Issue 3/2022
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-022-00490-2

Other articles of this Issue 3/2022

Ophthalmology and Therapy 3/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine